Manic episode without psychotic symptoms, mild
Methodology & AI Transparency ⓘ
Manic episode without psychotic symptoms, mild Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Recognized across U.S.
- 2 Real-world patient consensus: Diagnostic registry F30.11: Manic episode without psychotic symptoms, mild is managed within Depression & Mood.
- 3 Typical cash cost range: Differential triage of Manic episode without psychotic symptoms, mild (F30.11) utilizes medication response pharmacogenomics [Manic episode without psychotic symptoms, mild F30.11].
- 4 Top reported side effects / signs: Objective lab/clinical target for Manic episode without psychotic symptoms, mild: Serum Vitamin D in Manic episode without psychotic symptoms, mild (F30.11: & RBC Folate) (25(OH)D 40 – 65 ng/mL (F30.11)) and PHQ-9 Symptom Severity in Manic episode without psychotic symptoms, mild (F30.11: Score).
Ask our AI Specialists anything about Manic episode without psychotic symptoms, mild
What Is Manic episode without psychotic symptoms, mild?
Recognized across U.S. clinical coding as F30.11 (Depression & Mood), Manic episode without psychotic symptoms, mild is evaluated via medication response pharmacogenomics [Manic episode without psychotic symptoms, mild F30.11] to align day-to-day symptom relief with long-term physiological stability.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Manic episode without psychotic symptoms, mild (ICD-10 F30.11) is driven by neuroinflammatory microglial priming [Manic episode without psychotic symptoms, mild F30.11]; specialists in Depression, Bipolar & Mood Disorders monitor PHQ-9 Symptom Severity in Manic episode without psychotic symptoms, mild (F30.11: Score) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Manic episode without psychotic symptoms, mild (F30.11): persistent low mood, in Manic episode without psychotic symptoms, mild (F30.11: emotional flatness, or)
- • Secondary Manic episode without psychotic symptoms, mild clinical sign: disrupted sleep architecture [Manic episode without psychotic symptoms, mild F30.11]
- • Symptom flares in Manic episode without psychotic symptoms, mild correlating with Serum Vitamin D in Manic episode without psychotic symptoms, mild (F30.11: & RBC Folate) deviation outside 25(OH)D 40 – 65 ng/mL (F30.11)
- • Functional depression & mood impact requiring medication response pharmacogenomics [Manic episode without psychotic symptoms, mild F30.11] evaluation (F30.11)
Manic episode without psychotic symptoms, mild Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F30.11 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Depression, Bipolar & Mood Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: Serum Vitamin D in Manic episode without psychotic symptoms, mild (F30.11: & RBC Folate) | 25(OH)D 40 – 65 ng/mL (F30.11) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: PHQ-9 Symptom Severity in Manic episode without psychotic symptoms, mild (F30.11: Score) | < 4 (clinical remission) (F30.11) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: TSH & Free in Manic episode without psychotic symptoms, mild (F30.11: T4 Rule-Out) | TSH 0.8 – 2.5 mIU/L (F30.11) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Manic episode without psychotic symptoms, mild
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Lithium Carbonate Lithium Carbonicum, Lithobid • RxCUI 197892 | Mood Stabilizer | 92% | $0.1903 | $ 6.87 /mo |
| Lithium Lithium Generic • RxCUI RXN-72888172-2446 | Mood Stabilizer | 78% | $0.4424 | $ 26.42 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Manic episode without psychotic symptoms, mild)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Dimensions of anxiety in depression and their use in predicting antidepressant: What a 1,008-Participant Study Found Anxiety symptoms in people with MDD can be separated onto distinct factors that differentially respond to treatment outcome. Psychological medicine • 2020-04-15 • Randomized Controlled Trial | N = 1,008 | 90/100 | PMID 31023398 ↗ |
| Can This Approach Help? Inside the Latest Research on Gold-standard blind switch study of imipramine or sertraline treatment of More than 50% of chronically depressed antidepressant nonresponders benefited from a switch from imipramine to sertraline, or vice versa, despite a high degree of chronicity. Archives of general psychiatry • 2002-03-15 • Randomized Controlled Trial | N = 117 | 88/100 | PMID 11879161 ↗ |
| Can This Approach Help? Inside the Latest Research on White matter predicts tDCS antidepressant effects in a sham-controlled clinical Suggested better white matter microstructure of the left prefrontal cortex was associated with tDCS antidepressant effects. European archives of psychiatry and clinical neuroscience • 2023-10-15 • Randomized Controlled Trial | Multi-cohort | 88/100 | PMID 36336757 ↗ |
| Can This Approach Help? Inside the Latest Research on Association of platelet function with depression and its treatment with Heightened ADP-induced platelet aggregability was observed in CKD patients compared to controls with normal kidney function, regardless of presence of comorbid MDD, and treatment with sertraline did not affect platelet function. BMC nephrology • 2019-10-29 • Randomized Controlled Trial | N = 175 | 88/100 | PMID 31664940 ↗ |
| Can This Approach Help? Inside the Latest Research on Cariprazine on reducing symptoms of irritability, hostility, and agitation in Cariprazine demonstrated specific antihostility/irritability and anti-agitation effects in patients with manic/mixed episodes of bipolar I disorder and baseline hostility, irritability, or agitation. Journal of affective disorders • 2024-08-01 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 38657773 ↗ |
Manic episode without psychotic symptoms, mild Patient Community & “People Like Me” Threads
Filter Manic episode without psychotic symptoms, mild community threads and patient logs by age, biological sex, dosage, and treatment duration.